The local delivery of exogenous growth factors may help achieve a stable, l
onglasting prosthetic interface around primary and revision joint replaceme
nts. This study examines the effects of local infusion of transforming grow
th factor beta (TGF beta) in an in vivo model of tissue differentiation wit
hin bone. The Drug Test Chamber was implanted in the proximal medial tibial
metaphysis of 8 mature rabbits unilaterally. The chamber contained a 1 x 1
x 5 mm canal for tissue ingrowth, The chamber was connected to an osmotic
diffusion pump via polyvinyl tubing. 3.5 mu g of recombinant TGF beta 1 was
infused for 1 day or 1 week with subsequent harvesting of the ingrown tiss
ue after 3 weeks. Each TGF beta treatment was followed by two, 3-week infus
ions of carrier alone and harvesting of the ingrown tissue. TGF beta for 1
day increased, and TGF beta for 1 week decreased the percentage of bone in
the chamber, compared to the initial control harvest after carrier alone, T
hese changes, however, did not reach statistical significance. The number o
f vitronectin receptor positive cells in total, adjacent to bone and away f
rom bone was higher after treatment with TGF beta for 1 day, compared to 1
week. In an "unperturbed" bone ingrowth system (i.e., if bone ingrowth is n
ot initially suppressed by other stimuli), this dose of TGF beta did not en
hance hone ingrowth using the DTC model. (C) 2000 John Wiley & Sons, Inc. J
Biomed Mater Res (Appl Biomater) 53: 475-479, 2000.